VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Diabetic nephropathy (DN) is considered the primary causes of end-stage renal disease (ESRD) and is related to abnormal glycolipid metabolism, hemodynamic abnormalities, oxidative stress and chronic inflammation. Antagonism of vascular endothelial growth factor B (VEGF-B) could efficiently ameliorat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yilan, Chen, Wei, Han, Lei, Bian, Qi, Fan, Jiajun, Cao, Zhonglian, Jin, Xin, Ding, Tao, Xian, Zongshu, Guo, Zhiyong, Zhang, Wei, Ju, Dianwen, Mei, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838033/
https://www.ncbi.nlm.nih.gov/pubmed/33532185
http://dx.doi.org/10.1016/j.apsb.2020.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838033/
https://www.ncbi.nlm.nih.gov/pubmed/33532185
http://dx.doi.org/10.1016/j.apsb.2020.07.002

Ejemplares similares